DrugsAce

Tag: Anticancer Drugs

  • Adrenocorticoids

    Immunosuppressants ADRENOCORTICOIDS Methylprednisolone MEDROL, SOLU-MEDROL Prednisolone ORAPRED, PRELONE Prednisone Generic only

  • Anti Proliferatives

    Immunosuppressants ANTI-PROLIFERATIVES Azathioprine IMURAN Mycophenolate mofetil CELLCEPT Mycophenolate sodium MYFORTIC

  • Calcineurin & mTor Inhibitors

    Immunosuppressants CALCINEURIN INHIBITORS Cyclosporine NEORAL, SANDIMMUNE Tacrolimus ASTAGRAF XL, ENVARSUS XR, PROGRAF mTOR INHIBITORS Everolimus ZORTRESS Sirolimus RAPAMUNE

  • Immunosuppressants Antibodies

    Immunosuppressants ANTIBODIES Alemtuzumab CAMPATH Antithymocyte globulins ATGAM, THYMOGLOBULIN Basiliximab SiMULECT Rituximab RITUXAN

  • Tyrosine Kinase Inhibitors

    Anticancer Drugs TYROSINE KINASE INHIBITORS Afatinib GILOTRIF Dabrafenib TAFINLAR Dasatinib SPRYCEL Erlotinib TARCEVA Ibrutinib IMBRUVICA Idelalisib ZYDELIG Imatinib GLEEVEC Nilotinib TASIGNA Osimertinib TAGRISSO Pazopanib VOTRIENT Sorafenib NEXAVAR Sunitinib SUTENT Trametinib MEKINIST Vemurafenib ZELBORAF

  • Monoclonal Antiboies

    Anticancer Drugs MONOCLONAL ANTIBODIES Bevacizumab AVASTIN Cetuximab ERBITUX Daratumumab DARZALEX Panitumumab VECTIBIX Ramucirumab CYRAMZA Rituximab RITUXAN Trastuzumab HERCEPTIN

  • Steroides Hormones and Their Antagonists

    Anticancer Drugs STEROID HORMONES and THEIR ANTAGONISTS Anastrozole ARIMIDEX Bicalutamide CASODEX Enzalutamide XTANDI Exemestane AROMASIN Flutamide Generic only Fulvestrant FASLODEX Goserelin ZOLADEX Letrozole FEMARA Leuprolide LUPRON Nilutamide NILANDRON Raloxifene EVISTA Tamoxifen Generic only Triptorelin TRELSTAR

  • Microtubule Inhibitors

    Anticancer Drugs MICROTUBULE INHIBITORS Docetaxel TAXOTERE Paclitaxel TAXOL Vinblastine Generic only Vincristine VINCASAR PFS Vinorelbine NAVELBINE

  • Alkylating Agents

    Anticancer Drugs ALKYLATING AGENTS Busulfan MYLERAN Carmustine BICNU Chlorambucil LEUKERAN Cyclophosphamide CYTOXAN Dacarbazine Generic only Ifosfamide IFEX Lomustine GLEOSTINE Melphalan ALKERAN Temozolomide TEMODAR

  • Anticancer Antibiotics

    Anticancer Drugs ANTIBIOTICS Bleomycin Generic only Daunorubicin CERUBIDINE Doxorubicin ADRIAMYCIN, DOXIL Epirubicin ELLENCE Idarubicin IDAMYCIN Mitoxantrone Generic only

  • Antimetabolites

    Anticancer Drugs ANTIMETABOLITES Azacitidine VIDAZA Capecitabine XELODA Cladribine Generic only Cytarabine DEPOCYT Fludarabine Generic only 5-Fluorouracil ADRUCIL Gemcitabine GEMZAR 6-Mercaptopurine PURINETHOL Methotrexate (MTX) TREXALL Pemetrexed ALIMTA Pralatrexate FOLOTYN

  • Topotecan

    Brands Classes DEA Class; Rx Common Brand Names; Hycamtin Antineoplastics, Topoisomerase Inhibitors;  Antineoplastics, Camptothecin Description A camptothecin derivative, topoisomerase I inhibitorUsed for the treatment of small cell lung cancer, cervical cancer, and ovarian cancerCan cause severe myelosuppression; closely monitor complete blood counts Indications Indicated for SCLC sensitive disease after failure of first-line chemotherapy Indicated for…

  • Thalidomide

    Brands Classes DEA Class; Rx Common Brand Names; Thalomid Antineoplastics, Angiogenesis Inhibitor Description Biologic response modifier with immunomodulatory, antiangiogenic, and antitumor propertiesUsed for patients with erythema nodosum leprosum; also used in combination with dexamethasone for the treatment of patients with newly diagnosed multiple myelomaKnown teratogen that may cause birth defects or embryo-fetal death; routine testing…

  • Pomalidomide

    Brands Classes DEA Class; Rx Common Brand Names; Pomalyst Antineoplastics, Angiogenesis Inhibitor Description Biologic response modifier that is a thalidomide analogUsed for the treatment of adult patients with multiple myeloma or Kaposi sarcomaRisk of birth defects or embryo-fetal death if used during pregnancy; routine testing required; prescribers, pharmacies Indications Indicated in combination with dexamethasone, for…

  • Pembrolizumab

    Brands Classes DEA Class; Rx Common Brand Names; Keytruda Antineoplastics, Monoclonal Antibody;  PD-1/PD-L1 Inhibitors Description Programmed death receptor-1 (PD-1) blocking human monoclonal antibodyUsed for certain types of lymphoma, skin cancer, solid tumors, and tumors with genomic instability or a high mutational burdenSerious immune-mediated adverse reactions (e.g., pneumonitis, colitis, hepatitis, nephritis/renal dysfunction, hypothyroidism/hyperthyroidism) have been reported…